Navigation Links
"IVD Technology" Announces Upcoming Webcast: Omics and the Development of IVDs
Date:4/1/2011

LOS ANGELES, April 1, 2011 /PRNewswire/ -- UBM Canon and IVD Technology today announced an upcoming webinar in its webcast series on The Fundamentals of In Vitro Diagnostics. This one-hour event will focus specifically on Omics and the Development of IVDs and will offer an in-depth analysis and discussion from experts in the industry.

(Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

With the advent of the sequencing of the human genome, scientists have been hard at work seeking correlations between human disease and the architecture of individual genes, gene patterns, cellular pathways, and metabolic events. Such work has brought to the table a host of so called omics - genomics, proteomics, metabolomics - all of which are supposed to play a part in developing a personal genome for individuals.

This webcast will feature presentations by Alexandra Gruber, PhD, Director of Business Development, Biocrates Life Sciences AG; Louisa B. Tabatabai, PhD, Research Chemist, Respiratory Diseases and Immunology Research Unit, National Animal Disease Center, U.S. Department of Agric ulture; and Svetlana A. Dambinova, PhD, Professor at Wellstar College of Health and Human Services, Kennesaw State University. The Webcast concludes with a live Q&A session moderated by Richard Park, Editor-in-Chief of IVD Technology. For more information on the speakers, click here.

Richard Park, Editor-in-Chief of IVD Technology stated, "The editors of IVD Technology have put together an exceptional webcast, bringing together the leading experts in the field of omics who will give presentations and discuss omics-related challenges and issues that IVD manufacturers encounter. This is a rare opportunity to gain insight into the advances in the field of omics."

Attendees will also receive a copy of the DX Directions report on Omics and IVDs, included as a value-add with webcast registration.

The webcast will take place on Thursday, April 21 at 2:00 p.m. ET (1:00 p.m. CT, 11:00 a.m. PT). There is a small registration fee to attend. The event will be archived for six months on the IVD Technology website and UBM Canon Medical Device Media Group's webcast archive. For more information or to register for the webcast, please click here.

About UBM Canon

UBM Canon, the leading B2B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Ca non also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.


'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011
2. Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034
3. MedClean Technologies Announces 2010 Results
4. Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
5. Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis
6. AAIPharma Services Announces Promotion of Dean Shirazi
7. MedNet Solutions Announces the Release of iMedNet EDC
8. Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting
9. Fueling Interventional Radiology Growth: SIR Foundation Announces Navilyst Medical Pledge
10. Telik Announces Presentation and Webcast at 10th Annual Needham Healthcare Conference
11. AAIPharma Services Announces Compendial Testing Facility Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):